Streetbeat News

Earnings

HPE

Hewlett Packard (HPE) reported Q4 adjusted earnings per share (EPS) of $0.52, surpassing the consensus estimate of $0.50 by 4%. However, the company's earnings represent an 8.77% decline from the $0.57 per share reported in the same quarter last year. HPE's quarterly sales reached $7.351 billion, narrowly missing the consensus estimate of $7.352 billion by 0.01% and marking a 6.61% decrease from the $7.87 billion reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:08 pm

SPLK

Splunk (NASDAQ:SPLK) reported a significant increase in Q3 earnings to $0.55 per share, up from a loss of $(0.20) per share YoY. Sales also rose to $1.07B, a 14.80% increase from $929.77M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:08 pm

WDAY

Workday, Inc. has provided guidance for Q4 2024, expecting subscription revenue to reach $6.598 billion and adjusted operating margins to be 23.8%.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:08 pm

INTU

Intuit reported Q1 adjusted earnings per share (EPS) of $2.47, surpassing the estimated $1.98. Revenue for the quarter was $2.978 billion, also exceeding the forecast of $2.878 billion.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:05 pm

WDAY

Workday reported Q3 2024 adjusted earnings per share (EPS) of $1.56, surpassing the analyst estimate of $1.41. Revenue for the quarter was $1.87 billion, also exceeding the expected $1.848 billion.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 9:03 pm

CMND

Clearmind Medicine Inc. (NASDAQ:CMND) stock is trading higher after announcing positive results from its pre-clinical trial for a weight loss and metabolic disorder treatment. The trial tested a combination of Clearmind's MEAI and SciSparc's PEA, aiming to determine effective dosage, safety, and impact on metabolic and behavioral factors. The company's CEO highlighted the treatment's potential advantages over existing weight-loss drugs. The stock saw unusually high trading volume and was briefly halted before resuming.

Portfolio Pulse from Ryan Gustafson

November 28, 2023 | 8:55 pm

TMO

Thermo Fisher Scientific Inc. (NYSE:TMO) saw a 0.68% drop in its share price to $486.80 in the current market session. Despite a 9.45% increase over the past month, the stock has decreased by 13.11% over the past year. The company's P/E ratio of 32.12 is lower than the industry average of 37.9, which could suggest it is undervalued or expected to underperform compared to its peers in the Life Sciences Tools & Services industry.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 8:30 pm

CRM

EBIZ

XRT

Salesforce reported that Cyber Week US online sales hit $70.8B, marking an increase from $68B the previous year. This indicates a continued growth in e-commerce activity during a key shopping period.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 8:25 pm

SPHR

U2's residency at The Sphere in Las Vegas, titled 'U2:UV Achtung Baby Live at Sphere', has grossed $109.8 million from 17 shows, selling 281,000 tickets. With an average of $6.5 million and 16,500 tickets per show, the average ticket price was $390.97. This residency is the fastest grossing in Boxscore history, with potential to reach $330 million after all scheduled shows. The Sphere, a venue with a $2.3 billion cost, has been highlighted for its advanced audiovisual technology.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 8:18 pm

WDAY

Workday, Inc. (NASDAQ:WDAY) is expected to report higher earnings for its fiscal 2024 Q3, with analysts predicting $1.41 per share compared to $0.99 a year ago and revenues of $1.85 billion. Despite lowering its subscription growth guidance in September, analysts have updated their ratings and price targets. B of A Securities raised the target to $270, UBS to $245, Oppenheimer maintained at $255, Morgan Stanley cut to $245, and Barclays reduced to $249. Workday's stock closed slightly down at $235.83.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 7:42 pm